Susquehanna International Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7048 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7146 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7214 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6981 |
|
|
2022
Q1 | – | Sell |
-77,501
| Closed | -$361K | – | 6807 |
|
|
2021
Q4 | $361K | Buy |
77,501
+49,155
| +173% | +$229K | ﹤0.01% | 4260 |
|
|
2021
Q3 | $241K | Sell |
28,346
-4,723
| -14% | -$40.2K | ﹤0.01% | 4520 |
|
|
2021
Q2 | $543K | Buy |
33,069
+6,787
| +26% | +$111K | ﹤0.01% | 3785 |
|
|
2021
Q1 | $580K | Sell |
26,282
-15,050
| -36% | -$332K | ﹤0.01% | 3688 |
|
|
2020
Q4 | $1.28M | Buy |
41,332
+29,333
| +244% | +$907K | ﹤0.01% | 2248 |
|
|
2020
Q3 | $244K | Sell |
11,999
-27,943
| -70% | -$568K | ﹤0.01% | 3743 |
|
|
2020
Q2 | $614K | Buy |
39,942
+19,185
| +92% | +$295K | ﹤0.01% | 2700 |
|
|
2020
Q1 | $161K | Buy |
+20,757
| New | +$161K | ﹤0.01% | 3891 |
|